Renal Cell Carcinoma

Renal Cell Carcinoma News

  • Alert FDA Approves IO Combo for Advanced Renal Cell Cancer The approval of the nivolumab and ipilimumab combination provides a new first-line treatment option for a segment of patients with advanced renal cell carcinoma.
  • Oncology Prescribing Tied to Drugmaker Payouts Some oncologists may be more likely to prescribe certain cancer medicines when they receive payments from the companies that make these drugs, a U.S. study suggests.

Renal Cell Carcinoma Perspective

  • Beware of the Agreeable, Noncompliant Patient Many physicians are caught off guard when they face a malpractice lawsuit from a seemingly agreeable patient whom they have known for years. Is there any way to prevent this from happening?
  • GUCS 2018 Read clinically focused news coverage of key developments from GUCS 2018.